Orthocell Ltd (AU:OCC) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Orthocell Ltd, a regenerative medicine company, is set to hold its Annual General Meeting on November 29, 2024. Shareholders are encouraged to participate by submitting proxy forms and questions in advance. Orthocell’s innovative products, such as Striate+™ and Remplir™, continue to gain international approvals and are expanding in global markets.
For further insights into AU:OCC stock, check out TipRanks’ Stock Analysis page.